Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.
Eur J Dermatol
; 31(2): 183-191, 2021 Apr 01.
Article
in English
| MEDLINE | ID: covidwho-1352755
ABSTRACT
BACKGROUND:
COVID-19 poses significant challenges for care of patients with chronic inflammatory skin diseases including psoriasis.OBJECTIVES:
To investigate changes in treatment and/or appointments for psoriasis patients in a German university hospital due to the pandemic. MATERIALS &METHODS:
A postal survey was conducted between May 15 and June 15, 2020. Potential determinants of changes were analysed with descriptive statistics and multivariate logistic regression.RESULTS:
Out of 205 respondents, 19.5% missed an appointment and 9.8% changed therapy due to the pandemic. Treatment alterations were encouraged by patients (50%) and physicians (40%), whereas cancellations of appointments mostly occurred on patients' request (70%). Several patient-related key drivers of changes, including sociodemographic, disease- and health-related characteristics were identified. Changes in treatment and appointments were associated with higher psoriasis severity scores and more frequent disease aggravations.CONCLUSION:
It is particularly crucial to tailor psoriasis care to individual needs in order to protect the physical and mental well-being of patients during the pandemic.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Appointments and Schedules
/
Psoriasis
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Eur J Dermatol
Journal subject:
Dermatology
Year:
2021
Document Type:
Article
Affiliation country:
EJD.2021.4016
Similar
MEDLINE
...
LILACS
LIS